Ischemic Heart Disease Flashcards
types of ischemic heart disease
Angina Pectoris Chronic stable angina Unstable Angina Vasospastic (Prinzmetal's angina) Myocardial Infarction
angina caused by paroxysmal chest squeezing or pressure (can have sensation of smothering or impending doom)
angina pectoris
angina exacerbated by physical activity and relieved by rest or SL nitrogen
chronic stable angina
angina- increasing pattern of pain in previously stable patients (less responsive to meds, lasts longer, occurs with rest or little exertion)
unstable angina
angina occurring in pts due to a spasm of the coronary artery (more likely in morning, at rest. NOT brought on by exertion or emotional stress) Seen in young pts, smokers, or illicit drug users
Prinzmetal’s angina
how do you diagnose stable ischemic heart disease?
stress testing
drugs that decrease myocardial O2 demand
nitrates
calcium channel blockers
beta blockers
this drug increases myocardial O2 delivery by reversing coronary spasm
nitrates
these drugs relax resistance vessels (decrease afterload)
nitrates
CCB
beta blockers
these drugs relax capacitance vessels (decrease preload)
nitrates
CCB
these drugs block sympathetic influence on the heart (decrease contractility, HR, and O2 demand)
BB
these drugs dilate coronary arteries, increasing oxygen supply
nitrates
these drugs cause all segments of the vascular system to relax, resulting in pooling of blood in the veins (decreasing preload and work). They also dilate coronary vasculature and increase blood supply to the heart. Also decreases platelet aggregation
nitrates
this class has significant first pass effect in the liver, so you should distribute it transdermally or sublingually
nitrates
acute adverse effects of this drug include HA, orthostatic hypotension, facial flushing, and tachycardia
nitrates
tolerance with this drug occurs rapidly and manifests as tachyphylaxis (should be given 8 hours off per day)
nitrates
this drug interacts with sildenafil (viagra)
nitrates
mainstay formulation of nitroglycerin for immediate relief
sublingual
these are long acting nitrates, preferred for chronic stable angina
isosorbide dinitrate
isosorbide mononitrate
this class decreases myocardial O2 demand at rest and during exercise by decreasing HR and contractility, decreased CO
beta blockers
this class decreases sympathetic outflow inhibits release of renin from kidneys (decreased BP, afterload, and preload)
beta blockers
can be used for angina, post MI, HTN, anxiety
avoid in asthma/COPD, CHF, PVD, and vasospastic angina
beta blockers
adverse effects include sexual dysfunction, fatigue, insomnia, bradycardia, altered HLD and TG, and rebound HTN for abrupt withdrawal
beta blockers
this class can be used in angina (vasospastic and classic), HTN, supraventricular arrhythmias
CCB
contraindicated in pts with unstable angina
CCB
this class blocks inward movement of ca by binding to L-type calcium channels. Decreases TPR and afterload, increases coronary flow
CCB
ADRS: hypotension, effects related to vasodilation, gingival hyperplasia,
CCB
this CCB increases constipation, give with a stool softener. Also worsens CHF (negative inotropic effects)
verapamil
these CCBs can cause myocardial depression
verapamil
diltiazem
these CCBs cause tachycardia
nifedipine
nicardipine
this is a late CCB. it is primarily metabolized by CYP3A, so you cant use it with inducers or strong inhibitors or CYP3A
ranolazine
treat angina, no concomitant disease
long acting nitrate, BB, CCB
treat angina, pt had a recent MI
long acting nitrate, BB
treat angina, pt has asthma, COPD
long acting nitrate, CCB
treat angina, pt has HTN
(long acting nitrate), BB, CCB
treat angina, pt has DM
long acting nitrate, CCB
treat angina, pt has CRF
long acting nitrate, (beta blocker), CCB
should you combine nitrates with CCB or BB?
Yes
nitrates can cause increase in HR or contractility, and CCB and BB prevent this. BB and CCB can increase work, and nitrates decrease LVEDV
All pts with angina pectoris should be on
ASA BB ACEI LDL lowering therapy SL Nitroglycerin CCB or long acting nitrates
this drug shuld be used routinely in pts with acute and chronic ischemic heart disease. It exhibits an anti-thrombotic effect and reduces the risk of adverse events by 33% or risk of MI
ASA